2m 2m 2m 2m 2m 2m 2m
IMMUNOCORE SP ADS (IMCR)
NASDAQ
$32.04-$0.06 (-0.17%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.7BMarket Cap
- -1.29%1-Year Change
- BiotechnologyIndustry
IMMUNOCORE SP ADS (IMCR)
$32.04-$0.06 (-0.17%)
IMCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.09 | ||
Change | -$0.51 (-1.56%) | ||
Open | $32.60 | ||
High | $33.56 | ||
Low | $31.96 | ||
Previous Close | $32.60 | ||
Volume | 1,159,323 | ||
30-Day Average Volume | 523,592 | ||
1-Week Change | 13.23% | ||
1-Month Change | -0.28% | ||
1-Year Change | -1.29% | ||
3-Year Change | -32.11% | ||
5-Year Change | -14.97% | ||
Fundamentals | |||
Shares Outstanding | 51.5M | ||
Total Assets | $1.1B | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $115.9M | ||
Net Income | -$808,000.00 | ||
Free Cash Flow | $15.1M | ||
EBIT | $2.5M | ||
EBITDA | $3.6M | ||
Net Working Capital | $815.8M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | 437 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 4 | ||
P/E | -1,605 | ||
PEG | 15 | ||
Price/Free Cash Flow | 109 | ||
Price/Operating Cash Flow | 104 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue